Featured In: Forbes
06/24/2022
The U.S. Department of Veterans Affairs has launched clinical trials to study the effectiveness of psychedelic drugs including MDMA and psilocybin as a treatment for military veterans with post-traumatic stress disorder, addiction and other serious m
Featured In: The Economist
06/14/2022
IN AMERICA and Europe, a growing number of clinics are offering ketamine to treat depression. The anaesthetic—also used illegally as a party drug—can provide rapid relief from the condition where traditional treatments, such as antidepressant drugs,
Featured In: Benzinga
05/10/2022
With prior authorization from the VA, veterans will have the possibility to undergo therapy at KWC Arizona clinics in Phoenix, Tucson and Mesa-Gilbert at no out-of-pocket cost.
Featured In: The Dales Report
05/07/2022
Ketamine Wellness Centers announced the introduction of NAD+ infusion therapy at six of its clinic locations.
Featured In: Benzinga
05/04/2022
Delic Holdings Corp.’s DELCF subsidiary Ketamine Wellness Centers will start offering a new therapy in some of its locations: NAD+ infusion therapy.
Featured In: The Economist
04/23/2022
Interest is rising in the idea that ketamine, typically used as an anaesthetic (or as an illegal party drug), can help provide a lasting cure where traditional treatments, such as antidepressant drugs, have failed.
Featured In: Benzinga
03/30/2022
Ketamine Wellness Centers subsidiary of Delic Holdings Corp has expanded its treatment options to include SPRAVATO nasal spray.
Featured In: D Magazine
02/07/2022
Over the next year, Delic has plans to double its presence around the country, boosted by several states’ Veterans Administration approval of ketamine to treat pain for veterans.
Featured In: Behavioral Health Business
01/30/2022
Delic Holdings Corp., which trades on the Canadian Stock Exchange, has long had its eye on increasing its footprint in the American psychedelic wellness market.